NCT03998098

Brief Summary

This study validates Lifelight® First, a software application, in a laboratory setting. Participants will undergo testing to obtain measurements from one or more of the four vital signs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 29, 2019

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

May 13, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 25, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

July 26, 2021

Status Verified

July 1, 2021

Enrollment Period

2 years

First QC Date

May 13, 2019

Last Update Submit

July 23, 2021

Conditions

Keywords

Blood PressureSPO2Oxygen SaturationRespiratory RatePulseBreathing RateHeart Rate

Outcome Measures

Primary Outcomes (4)

  • Blood Pressure Readings Validation

    Agreement of Lifelight® First standard of care and range for blood pressure as per ISO 81060-2-Non-invasive-sphygmomanometers-Part 2-Clinical validation of automated measurement type

    Single Visit; up to one day

  • Oxygen Saturation Readings Validation

    Agreement of Lifelight® First standard of care and range for oxygen saturation as per ISO 80601-2-61-Medical electrical equipment-Part 2-61:Particular requirements for basic safety and essential performance of pulse oximeter equipment

    Single Visit; up to one day

  • Heart Rate (pulse) Readings Validation

    Agreement of Lifelight® First standard of care and range for heart rate (pulse) function as per ISO 80601-2-61- Particular requirements for basic safety and essential performance of pulse oximeter equipment

    Single Visit; up to one day

  • Respiratory Rate Readings Validation

    Agreement of Lifelight® First standard of care and range for respiratory rate by manually counting chest rises.

    Single Visit; up to one day

Study Arms (4)

Oxygen Saturation (Oximetry)

Arm to determine the performance of the Oxygen Saturation measurement in LifeLight First

Diagnostic Test: Oxygen Saturation (Oximetry)

Heart Rate (Pulse)

Arm to determine the performance of the Heart Rate measurement in LifeLight First

Diagnostic Test: Heart Rate (Pulse)

Respiratory Rate

Arm to determine the performance of the Respiratory Rate measurement in LifeLight First

Diagnostic Test: Respiratory Rate

Blood Pressure

Arm to determine the performance of the Blood Pressure measurement in LifeLight First

Diagnostic Test: Blood Pressure

Interventions

Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers

Also known as: Welch Allyn Connex Spot Monitor CSM 7500, LifeLight First
Oxygen Saturation (Oximetry)
Heart Rate (Pulse)DIAGNOSTIC_TEST

Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers

Also known as: Welch Allyn Connex Spot Monitor CSM 7500, LifeLight First
Heart Rate (Pulse)
Respiratory RateDIAGNOSTIC_TEST

Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers

Also known as: Two Clinical Observers, LifeLight First
Respiratory Rate
Blood PressureDIAGNOSTIC_TEST

Participants enter a chamber with a modifiable atmosphere and sit on a bench associated with an exercise bicycle. The subject breathes hypoxic air to achieve various SpO2 readings throughout the range of 80-97%. The participants undertake recumbent cycling for up to 10 minutes at various intervals and differing oxygen/nitrogen balances to induce changes in their vital signs. Measurements of the Vital Signs are taken at various time points using Lifelight First and the reference device using 2 observers For participants only participating in the Blood Pressure Arm of the trial, they will not be required to enter the normobaric chamber but will have their blood pressure readings taken in the ambient environment including lying supine in order to generate hypotensive readings.

Also known as: Welch Allyn Connex Spot Monitor CSM 7500, LifeLight First
Blood Pressure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The inclusion/exclusion criteria is limited to the intended use of the device, therefore only individuals, of any sex, over the age of 18 will be included in the study. The individuals for the purpose of the study have to be able to perform physical activity in the form of the ergometer if they are undertaking the exercise component.

You may qualify if:

  • Subject is informed and has been given ample time and opportunity to think about his/her participation and has given his/her written informed consent
  • Subject is ≥18 years of age
  • Subject's health status: individual is considered to be healthy (hypertension and hypotension is permissible. Other stable diseases at the time of testing are also permissible)
  • Subject is capable of undergoing controlled hypoxaemia to the levels called for the in the protocol with minimal medical risk (unless only participating in the blood pressure study).

You may not qualify if:

  • Subject cannot expose their face fully for a reading to be taken
  • Subject is unable to give informed consent
  • Subject is outside of the specified age range
  • Subject has already taken part in the study (all 4 sub studies)
  • Subject with significant irregular heart rhythm or any disease that might affect the results of the study
  • Subject is not capable of undergoing controlled hypoxia and would be placed at undue medical risk if this occurred
  • Subject has any contraindications identified that would deem them unsuitable to take part

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Portsmouth, Department of Sport and Exercise Science

Portsmouth, England, PO1 2HY, United Kingdom

Location

MeSH Terms

Interventions

Oxygen SaturationOximetryHeart RatePulseRespiratory RateBlood Pressure

Intervention Hierarchy (Ancestors)

MetabolismBlood Gas AnalysisBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative TechniquesVital SignsPhysical ExaminationHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaRespirationRespiratory Physiological Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2019

First Posted

June 25, 2019

Study Start

April 29, 2019

Primary Completion

May 1, 2021

Study Completion

May 1, 2021

Last Updated

July 26, 2021

Record last verified: 2021-07

Locations